Sobi HR chief buys nearly 30,000 shares

Lena Bjurner, HR chief at Sobi, has bought nearly 30,000 shares in the company for just over 7 million kronor.

The transaction took place on Monday according to market data.

Sobi is a specialist pharmaceutical company focused on rare diseases.

The deal amounts to just over 7 million kronor.

Verwandte Artikel

Fastpartner chairman Sven-Olof Johansson has bought 196600 shares in the company for a total of nearly 7.9 million kronor.

Von KI berichtet

Yubico chairman Patrik Tigerschiöld has acquired around 96,000 shares in the company through two separate transactions.

Modo recorded a deficit of 2.8 million kronor for the season that ended with a semifinal exit in HockeyAllsvenskan. CEO Johan Widebro described the steps taken to control spending without major cuts.

Von KI berichtet

The Timrå Party believes 2.1 billion kronor is too low a price for the Torsboda area to be sold to Google. They want better terms but still support the deal.

Sonntag, 19. Juli 2026, 23:52 Uhr

Cint CEO sells large portion of shareholding

Mittwoch, 15. Juli 2026, 07:35 Uhr

Neko Health valued at 67 billion kronor in major round

Montag, 29. Juni 2026, 21:13 Uhr

Wihlborgs buys 95 properties from Castellum for 13.3 billion kronor

Sonntag, 21. Juni 2026, 19:14 Uhr

Örbyhus Castle listed for sale at 400 million kronor

Montag, 15. Juni 2026, 19:00 Uhr

SpectraCure launches rights issue to finance studies

Freitag, 12. Juni 2026, 08:24 Uhr

Björklöven posts profit after SHL promotion

Freitag, 12. Juni 2026, 04:43 Uhr

Rögle BK invests in youth and junior development

Mittwoch, 10. Juni 2026, 14:57 Uhr

SD subsidiary bought books from Åkesson's publisher

Dienstag, 09. Juni 2026, 14:33 Uhr

Robin Svensk to lead RÖR project with 7.5 million kronor

Donnerstag, 04. Juni 2026, 12:42 Uhr

Peter Springare wins 1.7 million kronor on trotting

 

 

 

Diese Website verwendet Cookies

Wir verwenden Cookies für Analysen, um unsere Website zu verbessern. Lesen Sie unsere Datenschutzrichtlinie für weitere Informationen.
Ablehnen